Published in PLoS One on November 07, 2012
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med (1993) 7.85
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis (2005) 6.59
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56
HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res (2005) 3.05
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS (1999) 3.04
Tuberculosis and HIV co-infection. PLoS Pathog (2012) 2.57
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS (2000) 1.82
Tuberculosis and HIV co-infection in European Union and European Economic Area countries. Eur Respir J (2011) 1.80
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One (2011) 1.45
Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales. Int J Tuberc Lung Dis (2011) 1.21
Does tuberculosis increase HIV load? J Infect Dis (2004) 1.18
[Recommendations for therapy, chemoprevention and chemoprophylaxis of tuberculosis in adults and children. German Central Committee against Tuberculosis (DZK), German Respiratory Society (DGP)]. Pneumologie (2012) 1.12
Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region. HIV Med (2008) 1.10
Clinical management of tuberculosis in the context of HIV infection. Annu Rev Med (2004) 1.09
European framework to decrease the burden of TB/HIV. Eur Respir J (2004) 1.08
Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Eur Respir J (2011) 1.06
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment. Int J Tuberc Lung Dis (2007) 1.04
Cohort profile: the German ClinSurv HIV project--a multicentre open clinical cohort study supplementing national HIV surveillance. HIV Med (2010) 1.03
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort. PLoS One (2011) 1.00
The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results. Eur Respir J (2011) 0.97
HIV prevalence and testing practices among tuberculosis cases in London: a missed opportunity for HIV diagnosis? Thorax (2009) 0.95
A framework action plan to fight tuberculosis in the European Union. Euro Surveill (2008) 0.90
Problems to control TB in eastern Europe and consequences in low incidence countries. Monaldi Arch Chest Dis (2003) 0.87
[Aids and tuberculosis: coinfection from the perspective of the quality of life of patients]. Rev Esc Enferm USP (2012) 0.87
Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA (2008) 6.07
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis (2013) 4.87
Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol (2009) 4.36
Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med (2011) 4.02
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis (2005) 3.52
Assessment of an optimized mycobacterial interspersed repetitive- unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol (2006) 3.08
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS (2009) 2.50
Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge. Dtsch Arztebl Int (2010) 2.36
Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma. J Infect Dis (2009) 2.03
Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009. Am J Epidemiol (2010) 1.97
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS (2011) 1.65
Estimating the regional distribution of men who have sex with men (MSM) based on Internet surveys. BMC Public Health (2009) 1.51
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. Clin Infect Dis (2011) 1.50
Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016. Euro Surveill (2016) 1.48
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One (2011) 1.45
Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study. PLoS One (2011) 1.45
Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PLoS One (2012) 1.43
The first wave of pandemic influenza (H1N1) 2009 in Germany: from initiation to acceleration. BMC Infect Dis (2010) 1.39
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology (2013) 1.30
Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort. PLoS One (2010) 1.29
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
The denominator problem: estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys. BMC Public Health (2009) 1.26
HIV serosorting among HIV-positive men who have sex with men is associated with increased self-reported incidence of bacterial sexually transmissible infections. Sex Health (2011) 1.22
Transmission dynamics of pulmonary tuberculosis between autochthonous and immigrant sub-populations. BMC Infect Dis (2009) 1.21
Understanding recent increases in the incidence of sexually transmitted infections in men having sex with men: changes in risk behavior from risk avoidance to risk reduction. Sex Transm Dis (2006) 1.20
Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol (2005) 1.19
A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS (2009) 1.18
Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg Infect Dis (2014) 1.13
The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011. BMC Infect Dis (2012) 1.13
Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review. BMC Public Health (2007) 1.12
CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual. PLoS One (2008) 1.10
Influenza vaccination coverage in adults belonging to defined target groups, Germany, 2003/2004. Vaccine (2005) 1.08
Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS One (2011) 1.04
Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign. Vaccine (2006) 1.04
Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis (2007) 1.02
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort. PLoS One (2011) 1.00
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Severe cases of pandemic (H1N1) 2009 in children, Germany. Emerg Infect Dis (2011) 0.96
Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections. J Clin Microbiol (2007) 0.96
Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BMC Public Health (2008) 0.95
Estimates of excess medically attended acute respiratory infections in periods of seasonal and pandemic influenza in Germany from 2001/02 to 2010/11. PLoS One (2013) 0.94
Prevalence of C-terminal gag cleavage site mutations in HIV from therapy-naïve patients. J Infect (2008) 0.94
Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011. Emerg Infect Dis (2011) 0.93
Low-level Circulation of Enterovirus D68-Associated Acute Respiratory Infections, Germany, 2014. Emerg Infect Dis (2015) 0.92
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology (2012) 0.91
Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis (2014) 0.90
Unchanged severity of influenza A(H1N1)pdm09 infection in children during first postpandemic season. Emerg Infect Dis (2012) 0.88
Time trends of syphilis and HSV-2 co-infection among men who have sex with men in the German HIV-1 seroconverter cohort from 1996-2007. Sex Transm Infect (2010) 0.86
Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10. PLoS One (2011) 0.86
Major outbreak of hepatitis A associated with orange juice among tourists, Egypt, 2004. Emerg Infect Dis (2007) 0.85
Epidemiological Data - an Important Part of the Hemovigilance System. Transfus Med Hemother (2010) 0.85
A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008. Pediatr Infect Dis J (2011) 0.85
Syphilis in Germany, 2004: diagnoses increasing, particularly in smaller cities and rural areas. Euro Surveill (2005) 0.84
Protective measures and H5N1-seroprevalence among personnel tasked with bird collection during an outbreak of avian influenza A/H5N1 in wild birds, Ruegen, Germany, 2006. BMC Infect Dis (2009) 0.83
[Syphilis. Guideline of the German Sexually Transmitted Diseases Society fo diagnosis and therapy of syphilis]. J Dtsch Dermatol Ges (2006) 0.82
Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany. Hum Vaccin Immunother (2012) 0.82
Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS (2016) 0.81
Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J (2009) 0.80
Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002‒2011. Euro Surveill (2015) 0.80
Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls. BMC Public Health (2014) 0.80
The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort. BMC Infect Dis (2012) 0.79
Laboratory exposure to influenza A H2N2, Germany, 2004-2005. Emerg Infect Dis (2006) 0.79
Prevalence of Chlamydia trachomatis among young German adolescents, 2005-06. Sex Health (2011) 0.79
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling. BMC Public Health (2014) 0.78
Preventable and non-preventable risk factors for influenza transmission and hygiene behavior in German influenza households, pandemic season (H1N1) 2009/2010. Influenza Other Respir Viruses (2012) 0.78
Hepatitis B virus infections among children and adolescents in Germany: migration background as a risk factor in a low seroprevalence population. Pediatr Infect Dis J (2011) 0.77
Inferring HIV-1 Transmission Dynamics in Germany From Recently Transmitted Viruses. J Acquir Immune Defic Syndr (2016) 0.77
Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005. BMC Infect Dis (2010) 0.76
Large outbreak of hepatitis A in tourists staying at a hotel in Hurghada, Egypt, 2004--orange juice implicated. Euro Surveill (2005) 0.76
From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany. BMC Public Health (2015) 0.75
Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany. Influenza Other Respir Viruses (2013) 0.75
Rare pathologies. Dtsch Arztebl Int (2010) 0.75
[Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?]. MMW Fortschr Med (2010) 0.75
[New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)]. MMW Fortschr Med (2009) 0.75
[Influenza pandemic. Concept, basic principles, transmission]. Kinderkrankenschwester (2008) 0.75
Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe. PLoS Biol (2017) 0.75
Accelerated CD4+ cell count decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic. AIDS (2016) 0.75
[On the article by Rüdinger Meyer: Latent tuberculosis, Discussion on therapy in the USA. Pneumologie 2006; 60: 2]. Pneumologie (2006) 0.75
LILRA3 deletion is a genetic risk factor of HIV infection. AIDS (2017) 0.75
[High incidence and resistance rates in Eastern Europe. Is tuberculosis coming back?]. MMW Fortschr Med (2004) 0.75
Klaus Magdorf. 4 July 1942-23 January 2013. Eur J Pediatr (2013) 0.75